The developed asymmetric monovalent bispecific IgG1 or Duet monoclonal antibody (Duet mAb) has two distinct fragment antigen-binding region (Fab) subunits that target two different epitope specificities sequentially or simultaneously. The design features include unique engineered disulfide bridges, knob-into-hole mutations, and kappa and lambda chains to produce Duet mAbs. These make it structurally and functionally complex, so one expects challenging developability linked to instability, degradation of products and pathways, and limited reports available.
View Article and Find Full Text PDFJ Chromatogr B Analyt Technol Biomed Life Sci
April 2024
Developing a knob-into-hole asymmetric bispecific IgG1 monoclonal antibody (mAb) poses manufacturing challenges due to the expression of chain pairing variants, also called mispaired species, in the desired product. The incorrect pairing of light and heavy chains could result in heterogeneous mispaired species of homodimers, heterodimers, light chain swapping, and low molecular weight species (LMWS). Standard chromatography, capillary electrophoretic, or spectroscopic methods poorly resolve these from the main variants.
View Article and Find Full Text PDFBackground And Objective: Breast cancer is a frequently diagnosed cancer in women, contributing to significant mortality rates. Death rates are relatively higher in developing nations due to the shortage of early detection amenities and constraints on access to technical advances combating this disease. The only way to diagnose cancer with certainty is through biopsy performed by pathologists.
View Article and Find Full Text PDFComput Methods Programs Biomed
October 2020
Background And Objective: Breast cancer is a commonly detected cancer among women, resulting in a high number of cancer-related mortality. Biopsy performed by pathologists is the final confirmation procedure for breast cancer diagnosis. Computer-aided diagnosis systems can support the pathologist for better diagnosis and also in reducing subjective errors.
View Article and Find Full Text PDFJ Chromatogr B Analyt Technol Biomed Life Sci
December 2018
Modern analytical ion-exchange chromatography is one of the conventional tools used for assessment of product-related quality attributes in bio-therapeutic monoclonal antibodies (mAbs). Here, we present an approach to resolve, identify, and quantify product-related substances of therapeutic mAb at its intact molecular level by cation exchange (CIEX) HPLC coupled directly to electrospray ionization - quadrupole time of flight mass spectrometry (ESI-QTOF-MS). This method utilizes pH gradient elution mode comprised of ammonium formate buffer components, and a weak cation exchange column as stationary phase.
View Article and Find Full Text PDFWe present here extensive mass spectrometric studies on the formation of a Tris conjugate with a therapeutic monoclonal antibody. The results not only demonstrate the reactive nature of the Tris molecule but also the sequence and reaction conditions that trigger this reactivity. The results corroborate the fact that proteins are, in general, prone to conjugation and/or adduct formation reactions and any modification due to this essentially leads to formation of impurities in a protein sample.
View Article and Find Full Text PDF